(4R)-8-[5-(2,3-dichlorophenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine
C20H22Cl2N6S — CID 155796510
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-8-[5-(2,3-dichlorophenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine
(4R)-8-[5-(2,3-dichlorophenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine (PubChem CID 155796510) has the molecular formula C20H22Cl2N6S and a molecular weight of 449.41 g/mol. Its IUPAC name is (4R)-8-[5-(2,3-dichlorophenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine.
Molecular Properties
| Compound Name | (4R)-8-[5-(2,3-dichlorophenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine |
|---|---|
| PubChem CID | 155796510 |
| Molecular Formula | C20H22Cl2N6S |
| Molecular Weight | 449.41 g/mol |
| Exact Mass | 448.10 |
| IUPAC Name | (4R)-8-[5-(2,3-dichlorophenyl)sulfanyl-3H-imidazo[4,5-b]pyrazin-2-yl]-8-azaspiro[4.5]decan-4-amine |
| SMILES | N[C@@H]1CCCC12CCN(c1nc3ncc(Sc4cccc(Cl)c4Cl)nc3[nH]1)CC2 |
| InChI | InChI=1S/C20H22Cl2N6S/c21-12-3-1-4-13(16(12)22)29-15-11-24-17-18(25-15)27-19(26-17)28-9-7-20(8-10-28)6-2-5-14(20)23/h1,3-4,11,14H,2,5-10,23H2,(H,24,25,26,27)/t14-/m1/s1 |
| InChIKey | IZYCYQFOMKZCJZ-CQSZACIVSA-N |
| XLogP | 4.91 |
| TPSA | 83.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.41 |
| LogP ≤ 5 | 4.91 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155796510 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.